Skip to search boxSkip to navigationSkip to main content

Insights into the pathogenesis of axial spondyloarthropathy from network and pathway analysis

  • Jing Zhao(corresponding author)
    ,
  • ,
  • Ting Hong Yang
    ,
  • Petter Holme
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background: Complex chronic diseases are usually not caused by changes in a single causal gene but by an unbalanced regulating network resulting from the dysfunctions of multiple genes or their products. Therefore, network based systems approach can be helpful for the identification of candidate genes related to complex diseases and their relationships. Axial spondyloarthropathy (SpA) is a group of chronic inflammatory joint diseases that mainly affect the spine and the sacroiliac joints. The pathogenesis of SpA remains largely unknown.Results: In this paper, we conducted a network study of the pathogenesis of SpA. We integrated data related to SpA, from the OMIM database, proteomics and microarray experiments of SpA, to prioritize SpA candidate disease genes in the context of human protein interactome. Based on the top ranked SpA related genes, we constructed a SpA specific PPI network, identified potential pathways associated with SpA, and finally sketched an overview of biological processes involved in the development of SpA.Conclusions: The protein-protein interaction (PPI) network and pathways reflect the link between the two pathological processes of SpA, i.e., immune mediated inflammation, as well as imbalanced bone modelling caused new boneformation and bone loss. We found that some known disease causative genes, such as TNFand ILs, play pivotal roles in this interaction.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

S4

Journal (Volume, Issue Number)

BMC Systems Biology (Volume 6, Issue SUPPL.1)

Publication milestones

  • Published - 07/16/2012

Publication status

Published - 07/16/2012

ISSN

1752-0509

Publication IDs

  • Scopus: 84866441413
  • PubMed: 23046677

Publication metrics

Metrics

Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
citations
9
SciVal
FWCI
0.96
SciVal
Author count
4
SciVal
Paper percentile
63

PlumX, opens in new tab

Captures
17
Citation count
11

Funding Details

This research was supported by the National Natural Science Foundation of China(10971227); the Special Program for New Drug Innovation of the Ministry of Science and Technology, China (2009ZX09311-001, 2008ZX09101-Z-029); the Swedish Foundation for Strategic Research, the Swedish Research Council and the WCU program through NRF Korea funded by MEST R31-2008-10029-0. This article has been published as part of BMC Systems Biology Volume 6 Supplement 1, 2012: Selected articles from The 5th IEEE International Conference on Systems Biology (ISB 2011). The full contents of the supplement are available online at http://www.biomedcentral.com/ bmcsystbiol/supplements/6/S1.
FundersFunding numbers
NRF Korea
-
National Natural Science Foundation of China
-
Swedish Foundation for Strategic Research
-
SSF
-
NNSFC
10971227
MOST
2009ZX09311-001, 2008ZX09101-Z-029
MEST
R31-2008-10029-0
VR
-